Here we go again!
Treatment time.
Get checked lads
#prostatecancer

Join us in NYC or virtually on Oct. 8–9 to explore advances and key questions across the continuum of #ProstateCancer care, featuring tumor boards, panel discussions, and debates with multidisciplinary experts from @mskcancercenter.bsky.social and other leading institutions. 🔗 bit.ly/Prostate2026CME

Can early #ctDNA kinetics tell us more than PSA alone in #mCRPC?

This review examines ctDNA across ARPIs, chemotherapy, PARP inhibitors & PSMA-targeted radioligand therapy.

Read about the findings. https://bit.ly/4hepzeK
#ProstateCancer #LiquidBiopsy

Integrating single-cell imaging, multi-omics analyses, mechanistic studies, therapeutic modeling & a Phase Ib trial, our study identifies BCL-2 as a therapeutic vulnerability across heterogeneous CRPC.

Congrats to Anmbreen Jamroze, Dean G. Tang, Gurkamal Chatta & our team!
#ProstateCancer #BCL2

🔦2nd highlight from our Sept issue

A Chirindel & coll from University hospital of Basel report on the evaluation of the safety and clinical activity of [177Lu]Lu-PSMA-I&T in routine practice.

Read their study 🔓
bit.ly/4AApMAi

#medsky #radsky #prostatecancer

Dr. Victor Lee shared that patients with #prostatecancer & TP53 mutations had higher pathologic lymph node involvement. Noting incorporating TP53 mutational status into risk stratification models could improve patient selection for elective nodal irradiation. #ASTRO26 @oncoalert.bsky.social

A targeted form of radiotherapy is as effective as surgery for prostate cancer and has fewer side effects, a study has found www.telegraph.co.uk/news/2026/09... #prostatecancer #surgery

We’re kicking things off this Oct. 1–3 at Innovations in Urologic Practice and the Advances in Oncology Conference.

See where else you can find us throughout October. 👇

#ProstateCancer #Urology #Oncology #ArteraOnTheGo

🆕Our October issue is live!

📊Articles: #ovariancancer, #breastcancer, #multiplemyeloma, #prostatecancer, #lungcancer

📉Trials: KEYLYNK-001, CHN HYPOPMRT, SYMPRO-Lung trial, OPTIMUM/MUKnine, STAMINA

🎨Cover: Cancer & the microbiome

Read here: thelancet.com/issue/S1470-...

Proud of this work and grateful to everyone who made it possible.
#ProstateCancer #Immunotherapy #CancerResearch@KentNastiuk, Cancer Genomics & Urology @roswellpark.bsky.social

PS: Get yourselves checked guys!!!

#ProstateCancer sucks, but it doesn’t have to be a killer.
Here’s the @prostatecanceruk.bsky.social risk checker:
prostatecanceruk.org/risk-checker

Wow — hard to know what to say or where to begin: 5 years on and still going strong! It’s the 5th anniversary of my #ProstateCancer op today, so it’s time for some BIG shoutouts ⬇️

Prostate cancer care is evolving. ▶️ Watch this on-demand program exploring new disease terminology, earlier use of RLT, treatment sequencing, patient selection, and community implementation.

Watch now: vist.ly/5k7ju

#ProstateCancer #RLT #Urology

Among older dually enrolled veterans, #VeteransAffairs primary care was associated with lower #ProstateCancer screening and biopsy rates than fee-for-service #Medicare in men least likely to benefit. ja.ma/4ymgEhu

Interested in learning about the genes related to #prostatecancer & #ovariancancer ❓

This month, listen to this #sciencepodcast episode with Heather Cheng to learn more!

dnapodcast.com/episodes/202...

Fewer hospital visits for prostate cancer patients? A study found that 25 radiotherapy sessions after surgery achieved similar five-year cancer control to 37 sessions.

www.news-medical.net/news/2026092...

#ProstateCancer #Radiotherapy #CancerResearch #TCSC

Just giving this a little repost, please click share so it reaches the widest possible audience!!
Every penny goes straight to Clatterbridge
Thankyou!!!! #prostatecancer
#fuckcancer

NOW AVAILABLE! We're discussing the analysis of the SPPORT study in #prostatecancer just presented at the #ASTRO26 Clinical Trials Session. Find the NRG Oncology Podcast on Spotify, Apple Podcasts, Amazon, YouTube and stream www.NRGOncology.org/Podcast